Powder: -20°C for 3 years | In solvent: -80°C for 1 year
HIV-1 protease-IN-7 (compound 16) is an orally active inhibitor of HIV-1 protease, exhibiting an IC50 of 3.52 nM and an EC50 of 37 nM [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | HIV-1 protease-IN-7 (compound 16) is an orally active inhibitor of HIV-1 protease, exhibiting an IC50 of 3.52 nM and an EC50 of 37 nM [1]. |
In vivo | HIV-1 protease-IN-7 (2.57 mg/kg; p.o.; single) demonstrates favorable oral bioavailability and plasma total clearance [1]. |
Molecular Weight | 1285.68 |
Formula | C68H104N10O12S |
CAS No. | 2916441-36-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
HIV-1 protease-IN-7 2916441-36-4 Microbiology/Virology Proteases/Proteasome HIV Protease inhibitor inhibit